Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-04-23

Design Therapeutics (DSGN)

CEO Pratik Shah was paid $3,544,300 in fiscal year 2025, ↑ up 348.8% from fiscal year 2024 (SEC filing 0001193125-26-173678 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,544,300 ↑
Pratik Shah total, FY2025
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
—
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Pratik Shah (President, Chief Executive Officer and Chairperson), FY2025 total compensation $3,544,300 (base salary $395,000) [exec_comp, SEC accession 0001193125-26-173678, filed 2026-04-23]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

DSGN's next annual pay disclosure, estimated April 22, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Pratik Shah$395,000$144,000$0$2,754,300$237,000$0$14,000$3,544,300
President, Chief Executive Officer and Chairperson
Chris Storgard339,310144,72601,396,960135,724014,0002,030,270
Chief Medical Officer
Sean Jeffries484,0006,40001,193,530193,600014,0001,891,530
Chief Operating Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Pratik Shah$3,544,300$789,800$6,317,780↑ +2,754,500
Chris Storgard2,030,270———
Sean Jeffries1,891,5301,315,0021,283,615↑ +576,528

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Design Therapeutics's Summary Compensation Table. The whole free brief as a PDF, sent in 2 minutes, with every figure cited — then a few short notes on the deeper DSGN reports.

We send the PDF within 2 minutes, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against DSGN
No companies currently name DSGN as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Pratik ShahCEO$3,544,300
Chris StorgardChief Medical Officer$2,030,270
Sean JeffriesCOO$1,891,530
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Arsani William, M.DFormer director (through FY2025)$95,944
Deepa PrasadFormer director (through FY2025)$106,115
Heather Berger, Ph.DIndependent Director$109,714
John SchmidIndependent Director$120,714
Justin GoverIndependent Director$223,779
Rodney Lappe, Ph.DIndependent Director$239,035
Simeon George, M.DIndependent Director$136,672
02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Sean JeffriesOption49,0007.97—
Pratik ShahOption145,2507.97—
Pratik ShahOption600,0006.17—
Pratik ShahOption218,7502.48—
Pratik ShahOption437,5002.48—
Pratik ShahOption23,75012.77—
Sean JeffriesOption260,0006.17—
Sean JeffriesOption215,8342.54—
Sean JeffriesOption17,50012.77—
Chris StorgardOption400,0004.71—
05

Incentive-plan design — the Compensation Discussion & Analysis

The company aims to motivate and reward executives for achievements based on the level of achievement relative to corporate goals and expectations. Equity-based incentive awards are designed to align the interests of stockholders with those of employees by using stock options and restricted stock awards.

CEO STI target (% of salary)NaN%
CEO LTI target (% of salary)—
Independent consultantFW Cook
Clawback policyThe company has implemented a Dodd-Frank Act-compliant clawback policy as required by SEC rules. Additionally, the CEO may be legally required to reimburse the company for incentive-based compensation in the event of a material noncompliance with financial reporting requirements due to misconduct under Section 304 of the Sarbanes-Oxley Act.
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-09—————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-09—a

a. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Rodney Lappe, Ph.DIndependent · Research and Development (Chair) · Nominating and Corporate Governance (Chair)$65,000—$174,035——$239,035
Justin GoverIndependent · Audit · Compensation (Chair) · Newly elected3,109—220,670——223,779
Simeon George, M.DIndependent · Compensation81,958—54,714——136,672
John SchmidIndependent · Audit (Chair) · Compensation66,000—54,714——120,714
Heather Berger, Ph.DIndependent · Audit · Research and Development55,000—54,714——109,714
Deepa PrasadIndependent · Nominating and Corporate Governance · Departed during FY51,401—54,714——106,115
Arsani William, M.DIndependent · Departed during FY41,230—54,714——95,944
Pratik Shah, Ph.DEmployee director—————0
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)20,000 / 12,000 / 10,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$363,698
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$363,698

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

Year Ended December 31,
10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Design Therapeutics2025Pratik Shah$395,000$0$2,754,300$237,000$3,544,300

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at Design Therapeutics in fiscal 2025?
As disclosed, Pratik Shah (President, Chief Executive Officer and Chairperson) was the highest-paid executive at Design Therapeutics in fiscal 2025, with total compensation of $3,544,300.
How much does Design Therapeutics spend in total on board compensation for fiscal 2025?
As disclosed, Design Therapeutics reported total board compensation of $363,698 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Pratik ShahDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 3,544,300. Filing ↗machine: r2 · c23 · span 420474–420483
2Section 01, Chris StorgardDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 2,030,270. Filing ↗machine: r6 · c23 · span 454519–454528
3Section 01, Sean JeffriesDEF 14A2026-04-230001193125-26-173678Section “Executive Compensation”. As printed: 1,891,530. Filing ↗machine: r4 · c23 · span 437504–437513
4Section 08, Rodney Lappe, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 239,035. Filing ↗machine: span 704928–705137
5Section 08, Justin GoverDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 223,779. Filing ↗machine: span 700611–700820
6Section 08, Simeon George, M.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 136,672. Filing ↗machine: span 696014–696223
7Section 08, John SchmidDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 120,714. Filing ↗machine: span 709521–709730
8Section 08, Heather Berger, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 109,714. Filing ↗machine: span 718721–718930
9Section 08, Deepa PrasadDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 106,115. Filing ↗machine: span 714118–714327
10Section 08, Arsani William, M.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 95,944. Filing ↗machine: span 723326–723534
11Section 08, Pratik Shah, Ph.DDEF 14A2026-04-230001193125-26-173678Section “Director Compensation”. As printed: 0. Filing ↗
12Section 06, 2026 voteForm 8-K2026-04-230001193125-26-173678Item 5.07 · say-on-pay result. As reported: —. Filing ↗
13Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
14Section 09b board cost (computed)Computed——Cash 363,698 + equity 0 + all other 0 = 363,698, summed across the director compensation table rows.machine: formula: Σ = 363,698
15Design Therapeutics (subject), Section 10b CEO totalDEF 14A2026-04-230001193125-26-173678CEO total compensation as printed in Design Therapeutics's own proxy. As printed: 3,544,300. Filing ↗machine: r2 · c23 · span 420474–420483